Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease increased » degree increased (Expand Search), disease increases (Expand Search)
linear decrease » linear increase (Expand Search)
inter decrease » water decreases (Expand Search), teer decrease (Expand Search), step decrease (Expand Search)
Showing 81 - 100 results of 53,247 for search '(( significant decrease increased ) OR ( significant ((inter decrease) OR (linear decrease)) ))', query time: 0.50s Refine Results
  1. 81
    Comparison of mental health-related services utilization between the pre (2016–2019) and post (2020–2022) pandemic onset periods.

    Comparison of mental health-related services utilization between the pre (2016–2019) and post (2020–2022) pandemic onset periods. by Fernanda Talarico (807333)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 82
    Trend of all service utilization for all conditions between 2016 and 2022.

    Trend of all service utilization for all conditions between 2016 and 2022. by Fernanda Talarico (807333)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 83
    Linear regressions of consumer stable carbon and nitrogen isotope values and collection date.

    Linear regressions of consumer stable carbon and nitrogen isotope values and collection date. by Nathan D. McTigue (10706460)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 84
    Multivariable linear regression analyses for predicting factors.

    Multivariable linear regression analyses for predicting factors. by Maurice Pradella (11678817)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 85
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 86
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 87
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  8. 88
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  9. 89
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 90
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 91
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 92
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 93
    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of <i>Clostridioides difficile</i> infection (CDI) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phas... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 94
    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 95
    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 96
    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of penicillin-resistant <i>Streptococcus pneumoniae</i> (PRSP) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 97
    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the incidence of resistant <i>Haemophilus influenzae</i> per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).... by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 98
    Linear regression analysis results for the effect of log-transformed urinary BPA concentrations at two time points on serum thyroid concentrations at ages 10–12.

    Linear regression analysis results for the effect of log-transformed urinary BPA concentrations at two time points on serum thyroid concentrations at ages 10–12. by Jung Eun Choi (563339)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 99
    Significant inter-relationships between baseline variables and MSCC or MCS.

    Significant inter-relationships between baseline variables and MSCC or MCS. by Harshit Arora (22008280)

    Published 2025
    Save to List
    Saved in:
  20. 100
    Estimated marginal means of the RMS per muscle, based on the linear mixed-effects model.

    Estimated marginal means of the RMS per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

    Published 2022
    Subjects:
    Save to List
    Saved in:

Search Tools: